AA
Antipodean Advisors Portfolio holdings
AUM
$19.5M
This Quarter Return
+1.26%
1 Year Return
-6.2%
3 Year Return
-67.79%
5 Year Return
+39.8%
10 Year Return
+908.88%
AUM
$353M
AUM Growth
+$353M
(-2.7%)
Cap. Flow
+$8.93M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
3
Increased
1
Reduced
1
Closed
2
Top Buys
| 1 |
Invivyd
IVVD
|
$8.03M |
| 2 |
ICICI Bank
IBN
|
$7.55M |
| 3 |
NKLA
Nikola Corporation Common Stock
NKLA
|
$1.07M |
| 4 |
Atara Biotherapeutics
ATRA
|
$895K |
Top Sells
| 1 |
Clarivate
CLVT
|
$3.29M |
| 2 |
Clover Health Investments
CLOV
|
$3.13M |
| 3 |
Lemonade
LMND
|
$2.19M |
Sector Composition
| 1 | Consumer Discretionary | 66.47% |
| 2 | Communication Services | 15.18% |
| 3 | Healthcare | 9.24% |
| 4 | Technology | 6.98% |
| 5 | Financials | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Carvana
CVNA
$51.4B
| $122M | 34.58% |
405,000
| – | – |
|
2
Sea Limited
SE
$110B
| $112M | 31.59% |
350,000
| – | – |
|
3
Cardlytics
CDLX
$54.3M
| $53.6M | 15.18% |
638,800
| – | – |
|
|
4
Clarivate
CLVT
$2.92B
| $24.6M | 6.98% |
1,125,000
-150,000
| -12% | -$3.29M |
|
|
5
Atara Biotherapeutics
ATRA
$84.6M
| $18.8M | 5.32% |
1,050,000
+50,000
| +5% | +$895K |
|
|
6
Invivyd
IVVD
$204M
| $8.03M | 2.27% |
+190,000
| New | +$8.03M |
|
|
7
ICICI Bank
IBN
$113B
| $7.55M | 2.14% |
+400,000
| New | +$7.55M |
|
|
CMAX
8
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.8M | 1.64% |
600,000
| – | – |
|
|
NKLA
9
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.07M | 0.3% |
+100,000
| New | +$1.07M |
|
|
10
Clover Health Investments
CLOV
$1.34B
| – | – |
-235,000
| Closed | -$3.13M |
|
|
11
Lemonade
LMND
$3.91B
| – | – |
-20,000
| Closed | -$2.19M |
|